Aligning Science Across Parkinson’s (ASAP) and The Michael J. Fox Foundation for Parkinson’s Research (MJFF) are together investing…
Andrea Lobo
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo
Routine gut biopsies may turn up evidence of protein misfolding, predicting the risk of developing neurodegenerative diseases such as Parkinson’s…
The U.S. Food and Drug Administration (FDA) has given a green light to the new Cala kIQ Plus system,…
Amprion is partnering with Macquarie University in Australia to expand access to its SAAmplify-alphaSYN…
Researchers at Florida International University (FIU) have identified a compound that boosts the function of mitochondria (cells’ powerhouses) and may…
Bial has launched an international education campaign to support clearer communication and the early identification of symptoms among people…
Rune Labs has launched StrivePD Guardian, a personalized artificial intelligence (AI) companion tool that helps people with…
The Parkinson’s Foundation‘s largest annual fundraiser — Moving Day, A Walk for Parkinson’s — is marking its 15th anniversary,…
Serina Therapeutics has entered into definitive agreements for a private placement that could provide up to $30 million to…
Treatment with pirepemat, an oral medication in the pipeline at Irlab Therapeutics AB, may help reduce the risk of…